ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC
GlobeNewswire· 2025-05-27 12:00
Conference Call and Webcast on Wednesday, May 28, 2025, at 4:30 p.m. ETSOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that the company will present initial data from the Phase 1b trial of ORIC-944 in combination with androgen receptor inhibitors in patients with metastatic castration resistant prostate ca ...
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire· 2025-05-27 12:00
SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the Goldman Sachs 46th Annual Global Healthcare Conference. Nautilus’ management is scheduled to participate in a fireside chat on Tuesday, June 10, 2025, at 2:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on ...
Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
GlobeNewswire· 2025-05-27 12:00
NEWTOWN, Pa., May 27, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, today announced receipt of written responses to questions submitted for a Type B pre-Investigational New Drug Application meeting with the U.S. Food and Drug Administration (FDA, the Agency). The FDA provided feedback on development paths fo ...
ORYZON to Provide Corporate Progress Updates at Several Events in May-June
GlobeNewswire· 2025-05-27 12:00
Foro MedCap 2025BIO International Convention 2025 Discovery and Development Europe 2025 MADRID and CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its management will give an update on corporate progress at several international events in May-June. Oryzon will attend the Foro Medcap 2025, which will take place at the Madrid Stock Exchange palace in Ma ...
Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025
GlobeNewswire· 2025-05-27 12:00
Vadadustat clinical data on display for nephrologists and healthcare providersCAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced it will present data at the 62nd European Renal Association (ERA) Congress on June 4-7, 2025, both virtually and live in Vienna. Akebia-supported presentations at ERA Congress 2025: A Win-Ratio Analysis of the Cardiovascu ...
Ascent Solar Technologies Signs Master Services Agreement to Provide NOVI Space with Rollable PV Array Blankets for Launch in 2026
GlobeNewswire· 2025-05-27 12:00
THORNTON, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies (“Ascent” or the “Company”) (Nasdaq: ASTI), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today announced the signing of a Master Services Agreement with NOVI Space, Inc. (“NOVI”), a Virginia-based space company that develops and operates AI-powered satellites with their TRL-9 edge computing technology. Ascent has been contracted to provide rollable PV ar ...
Check Point to Acquire Veriti to Transform Threat Exposure Management and Reduce Organizations' Cyber Attack Surface
GlobeNewswire News Room· 2025-05-27 12:00
REDWOOD CITY, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- AI-fueled attacks and hyperconnected IT environments have made threat exposure one of the most urgent cybersecurity challenges facing enterprises today. In response, Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a pioneer and global leader of cyber security solutions, today announced a definitive agreement to acquire Veriti Cybersecurity, the first fully automated, multi-vendor pre-emptive threat exposure and mitigation platform. “The acquisit ...
Murray Brook Minerals, Puma’s Subsidiary, Closes $220,000 Private Placement
GlobeNewswire· 2025-05-27 12:00
RIMOUSKI, Quebec, May 27, 2025 (GLOBE NEWSWIRE) -- Puma Exploration Inc. (TSXV: PUMA) (“Puma”), announces that its subsidiary, Murray Brook Minerals Inc. (“MBM” or “Murray Brooks Minerals”) has closed a non-brokered offering consisting of 4,400,000 flow-through common shares (the "FT Shares") of MBM at a price of C$0.05 per FT Share for aggregate gross proceeds of $220,000 (the “FT Offering”). Following the FT Offering, Murray Brook Minerals has now 28,044,165 common shares issued and outstanding, with no w ...
Hydreight Launches Personalized Genetic Testing and Wellness Solution on VSDHOne Platform
GlobeNewswire· 2025-05-27 12:00
Expands access to precision-based care through at-home DNA testing and personalized health plansVANCOUVER, British Columbia and LAS VEGAS, May 27, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform delivering compliant mobile and telehealth services across all 50 U.S. states, is pleased to announce the launch of a new direct-to-consumer genetic testing and personalized wellness solution via its VS ...
Multi Ways Holdings Reports Financial Results for Fiscal Year 2024
GlobeNewswire· 2025-05-27 12:00
SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) -- Multi Ways Holdings Limited (“Multi Ways”, the “Company” or the “Issuer”) (NYSE American: MWG), a leading supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region, today announced fiscal year 2024 financial results. "We are pleased to report on the strategic advancements Multi Ways Holdings Limited has achieved over the past year," said Mr. James Lim, Chairman and Chief Executive Officer of Multi Ways Ho ...